Clinical Study
Consistency of Mycobacterium tuberculosis-Specific Interferon-Gamma Responses in HIV-1-Infected Women during Pregnancy and Postpartum
Table 2
(a) Odds of consistently positive interferon-γ release assays in women associated with baseline magnitude of interferon-γ response >8 compared to ≤8 SFCs/well. (b) Odds of >50% postpartum visits with positive interferon-γ release assays in women with baseline magnitude of interferon-γ response >8 compared to ≤8 SFCs/well.
(a) | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
(b) | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
Note: IGRA interferon-gamma release assay. *Maximum of ESAT-6/CPF-10 minus negative control. |